[1]
“Clinical Evaluation of the Significance of FGFR2/3 Genomic Alterations in Urothelial Cancer: A Retrospective Analysis”, Вопр. онкол., vol. 70, no. 4, pp. 685–695, Sep. 2024, doi: 10.37469/0507-3758-2024-70-4-685-695.